Scott Robinson
Analyst · Oppenheimer
Thanks, Tod. Good morning, everyone. Every way we look at it, fiscal 2021 was a solid year. We generated strong sales despite the pandemic hanging over us and margin growth contributed to record full-year EPS. What was more impressive was how our people operated. The level of teamwork was unbelievable. And I'm inspired by the commitment they showed. I want to thank my colleagues around the world for all they did in fiscal 2021 and for putting us in an excellent position to deliver record sales and profit in fiscal 2022. Before getting to the details of the new year, let me share some 2021 highlights. Fourth quarter sales grew 25%. Operating income was up 36%. And EPS of $0.66 was 32% above the prior year. As I know you've heard me say, we are committed to increasing levels of profitability on increasing sales. And we did that in 2021. I want to add a short disclaimer. That commitment is over time, and it won't be easy to achieve in the first half of fiscal 2022. I'll touch on that in a few minutes. So, back to the fourth quarter recap. Fourth quarter operating margin was 14.5%, an increase of 110 basis points from the prior year. Most of the increase was from gross margin, which grew 70 basis points to 34.4%. Strong volume leverage and initial pricing benefits more than offset the impact from higher raw material costs and mix headwinds. The impact on raw materials increased throughout the quarter as inflation has begun coming through in full force. We were in front of this impact with price increases in certain businesses, while increases in areas with supply agreements that had index clauses tend to lag the market. That's true when prices go up or down, so it works out over time. Leverage and pricing also accounted for higher fourth quarter gross margin in both segments. However, challenges from inflation and unfavorable mix will likely be the theme in fiscal 2022. Operating expenses as a rate of sales was favorable at 40 basis points, driven primarily by volume leverage. That was true of both segments, with industrial gaining a lot of improvement in leverage. The strong volume leverage was partially offset by higher incentive compensation due in part to a soft comparison last year and incremental investments in our strategic growth priorities, which will continue in fiscal 2022. I also want to touch on corporate and unallocated line in our segment reporting. The fourth quarter increase of almost $10 million reflects a couple of factors. This year's expense, which includes additional incentive compensation and higher benefit costs and a much easier comparison in the prior year. Moving down the P&L, fourth quarter other income was $5 million. While the amount itself was not material, I bring it up because we ended the year above our guidance. So, in case there are questions, the favorability reflects a handful of non-recurring items, including a tax settlement in Brazil and lower loss on foreign exchange. In terms of our other financial metrics, fourth quarter was in line with expectations. Therefore, our full-year interest expense and tax rate were both consistent with guidance. Fiscal 2021 capital expenditures were also in line with our forecast and way down from 2020 as we took a plan pause following the investment cycle over the past three years. We directed about a quarter of a billion dollars to shareholders in fiscal 2021. We repurchased 1.9% of our outstanding shares for 142 million and we paid dividends of $107 million. Including the 5% increase we announced earlier this year, we are on pace for more than 25 years in a row of annual dividend increases, which is a trend we are extremely proud of. I also want to highlight the fiscal 2021 adjusted cash conversion of 116%. Our DSO and DPO metrics were both favorable versus the prior year. Inventory turns improved and CapEx was down. While strong net income obviously helped our cash conversion, I am pleased with the way we managed our balance sheet. We continue to have the flexibility we need to invest in our strategic priorities, including organic and inorganic growth. That should set up our fiscal 2022. We begin the year on solid ground, and we are well positioned to deliver our objectives. Before getting into the details, I want to acknowledge that there is still a lot of economic uncertainty and high variability across our end markets and geographies. Based on that, we used wide ranges for total and segment level guidance to reflect our reality. Of course, we will tighten things up as the year progresses. With that, fiscal 2022 sales are expected to grow between 5% and 1% with currency translation being negligible. Engine is also planned up between 5% and 10% and Industrial is a bit higher at 6% to 11%. Within Engine, sales of our first-fit businesses are expected to remain healthy, particularly in the first half of the year. Fiscal 2022 onroad sales are planned up in the low-single digits, while offroad are projected how in the low-double digits. The offroad first fit growth also includes benefits from new programs in exhaust and emissions, which gives us top line leverage and gross margin mix headwinds. For engine aftermarket, we expect full-year sales growth in the mid-single digits, with equipment utilization being complemented by share gains from our innovative products and underpenetrated markets. We anticipate low-double digit growth in aerospace and defense due in large part to comparing against the challenges of fiscal 2021. Sales of Industrial Filtration Solutions are planned up in the low-double digit range, reflecting a few things. We expect a rebound in sales of new equipment, particularly for dust collection, and continued growth in dust collection replacement parts. We also expect another year of strong growth in Process Filtration, which reflects benefits from further investments to expand the team. Fiscal 2022 sales in GTS are planned up in the high-single digits, while sales of special applications are planned down in the low-single digits. Within special applications, we expect lower sales of disk drive filters should be partially offset by growth in venting solutions. In terms of operating margin, we expect a full-year rate between 14.1% and 14.7%. This range implies an increase of 10 basis points to 70 basis points from the fiscal 2021 adjusted operating margin, and we expect the improvement to come from expense leverage. Gross margin is expected to be flat to slightly down from the prior year, with raw materials being the single biggest headwind. At today's prices, we expect to pay 8% to 10% more for our raw materials this year, and that translates to a gross margin impact of nearly 3 full points in fiscal 2022 margin. There is still a lot of variability, and where prices have come down some, it is only a modest change relative to the massive runup over the past few months. So, we do not yet have signs of meaningful relief. And one final dynamic to keep in mind is that we had raw materials favorability during the first half of fiscal 2021. Consequently, we expect substantial pressure on our first half gross margin, and then moderating pressure as the timing of our price increases roll in and catch up to the current market pricing. Importantly, we have already taken action to limit the impact. We implemented several off-cycle pricing actions over the past few months and we have more planned for this fiscal year. But those will take time to roll in. As benefits from pricing compound and costs stabilize, we anticipate gross margins in the second half of fiscal 2022 should be up versus 2021. Restructuring actions we initiated in fiscal 2021 will help reduce the impact a bit. We continue to expect annualized savings of about $8 million, with about $5 million to $6 million landing in fiscal 2022. A large portion of these savings benefit operating expense, and there are a handful other puts and takes we considered in our operating expense budget. For example, we anticipate savings from incentive compensation as we reset our annual bonus plan. And we expect to increase traveling expense as the pandemic-related restrictions subside and we get back to visiting customers. We are also making incremental investments in our advanced and accelerate businesses, including another 10% increase in research and development spending. Altogether, we expect total operating expenses will be up from the prior year, but to a lesser extent than sales, resulting in net leverage that drives year-over-year growth in operating margin. In terms of other key financial metrics, fiscal 2022 interest expense is planned to be about $14 million. Other income is projected between $7 million and $11 million, and the tax rate is expected between 24% and 26%. Capital expenditures are planned up in fiscal 2022 with a full year estimate of $100 million to $120 million. We are expanding PowerCore capacity, primarily in North America, and investing in [indiscernible], our new programs and cost reduction initiatives. At the same time, we will further optimize and leverage the investments we made a few years ago, with the goal of growing ROI again this year. Additionally, we expect to repurchase about 2% of our shares in fiscal 2022, keeping with our multi-decade trend and reaffirming our commitment to shareholders. Finally, we will maintain a strong balance sheet to allow us to act on any acquisition opportunities in the life sciences space. Based on these forecasts, we plan for a new EPS record between $2.50 and $2.66 and applying an increase from last year's adjusted EPS of 8% to 15%. To help with modeling, I want to also offer a few comments about the anticipated cadence of results in fiscal 2022. It's actually pretty straightforward. The first half has an easier sales comparison, meaning we plan for more of our full-year increase to come from the first half and the second. The reverse is true for our operating margin. As I said a moment ago, gross margin will be under substantial pressure in the first half. While we foresee expense leverage all year, it won't be enough in the first half. Then as things normalize and pricing takes hold, operating margin should be up year-over-year in the second half. Overall, our company has a long history of solid expense management and we have responsible leaders across the world that will invest where appropriate. What we need to do is achieve pricing. And that takes a global coordinated response. We talked about it a lot during our planning process. And I know every level of the organization is committed to protecting gross margin and delivering another year of strong profit improvement. I think we are in an excellent position to deliver on our strategic and financial goals in fiscal 2022 due to the dedicated employees around the world. To all my Donaldson colleagues, I want to thank you again for a great year and your continued commitment to our long-term success. I'll now turn the call back to Tod. Tod?